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resumo 
 
 
A ameaça emergente de doenças infecciosas originadas por estirpes de 
bactérias multi-resistentes está a causar grandes preocupações a nível 
mundial, especialmente devido ao aumento de infecções nosocomiais em 
unidades de saúde, colocando um grande perigo para os sistemas de saúde 
pública. Existem já evidências directas da transferência de genes de 
resistência de organismos marinhos para o ser humano através de vários 
mecanismos, tais como a Transferência Horizontal de Genes, com potenciais 
reservatórios e vectores ainda por determinar. Os efeitos  da má utilização de 
antibióticos e outros compostos antimicrobianos no microbiota do tracto 
gastrointestinal (GIT) de espécies com algum grau de contacto com materiais e 
detritos humanos e que poderão constituir-se como vectores para uma 
variedade de estirpes de bacterias multi-resistentes, ainda permanecem 
desconhecidos. O presente estudo teve como objectivo principal  determinar a 
existência de estirpes bacterianas resistentes a antibióticos em Solea spp. No 
contexto da saúde pública. Foram realizados testes de inibição de Kirby-Bauer 
em animais de duas aquaculturas e dois portos de pesca localizados a norte e 
a sul do rio Douro. Os resultados revelaram resistência para a penicilina em 
todos os locais de amostragem. Resistência à amoxicilina com ácido 
clavulânico foi verificada nos locais A, B, e no C com alguns resultados de 
nível intermédio. No local D a sensibilidade a este composto foi total. O nível 
de inibição foi intermédio para o trimetoprim-sulfametoxazol (SXT) e para a 
ciprofloxacina no local A. O local B e D revelaram sensibilidade para ambos e 
o C apresentou resistência ao SXT e inibição intermédia pela ciprofloxacina. 
Considera-se, assim, que o mau uso de antibióticos foi a causa mais provável 
da indução de resistências no microbiota do GIT da Solea spp. e que o 
potencial para ocorrer transferência de genes de resistência ao contexto 
humano é elevado.  
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abstract 
 
Great concerns are developing worldwide over the emerging threat of infectious 
diseases caused by antibiotic-resistant strains of bacteria, especially for the 
rise of nosocomial infections in healthcare units, placing a major peril over 
public health systems. There are evidences of resistance genes being 
transferred from marine life to humans by several mechanisms such as 
Horizontal Gene Transfer (HGT), with potential reservoirs and vectors still to be 
determined. The effects caused by antibiotics and other antimicrobial 
compounds misusage on the gastrointestinal tract (GIT) microbiota of species 
with some degree of contact with human materials or wastes that could present 
themselves as vectors for a variety of resistant strains of bacteria still remain 
unknown. The main goal of this study was to determine the existence of 
antibiotic-resistant strains of bacteria in the Solea spp. in the public health 
context. Kirby-Bauer inhibition tests were performed in animals of two 
aquaculture industries and two fishing harbors located north and south of the 
Douro river. Results revealed a high resistance for penicillin in all sampling 
locations. Resistance to amoxicillin with clavulanic acid was obtained in sites A, 
B and C with few results of intermediate level. In location D the sensibility for 
this compound was total. The level of inhibition was intermediate for 
trimethoprim-sulfamethoxazole (SXT) and ciprofloxacin in site A. Sites B and D 
revealed sensitivity to both and location C presented resistance to SXT and 
intermediate resistance to ciprofloxacin. It was considered that antibiotics 
misusage was the most probable cause for inducing resistance in the GIT 
microbiota of the Solea spp and the potential for transfer of the genetic 
determinants of resistance to the human setting is high. 
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1. Introduction 
 
 The rising emergence of antibiotic-resistant strains of bacteria and the 
intrinsic increase in nosocomial or health care units-associated infections is one of 
the greatest dangers presently posed to human health and it is already one of the 
most important issues in public health discussions and policy making (3; 6-8; 26; 
35; 49).  
 The width of the effect caused by the antibiotic-resistant strains of bacteria 
and their extensive impact on both morbidity and mortality, has taken the 
European Union to treat it as a special health issue listed in Annex 1 of the 
European Commission Decision 2000/96/EC of the 22nd of December, 1999 and 
also the United States government, for example, to consider multidrug-resistant 
microorganisms a significant threat to their public health and national security (3; 
7; 8; 10; 16; 33; 59).  
 Estimates showed that roughly 160 newly Emerging Infectious Diseases 
(EID) caused by bacteria have gradually been identified over the last 70 years (49; 
65). This EID increase is usually connected to certain agricultural practices, 
climate changes (affects the survival and distribution of disease vectors such as 
insects), and increases in human population densities, originating an augmented 
disease incidence (49; 65). Epidemics related to antibiotic resistance have already 
been described in a range of pathogens such as the global proliferation of drug 
resistance among common respiratory pathogens (e.g. Streptococcus 
pneumoniae and Mycobacterium tuberculosis) and episodes of epidemic 
increases in multidrug-resistance in gram-negative bacilli (8).  
 The specific issue concerning oceanic fish species is that the frequent 
contamination of coastal ecosystems with discarded antibiotics from clinical, 
industry and agricultural activities, through discharged effluents and runoffs, 
invariably results in the amplification of the selective pressures out of the 
parameters normally occurring in the ecosystems, therefore, creating favorable 
settings for the appearance of antibiotic-resistant strains of EID causing bacteria 
(3; 7). 
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  The scientific emphasis, at the moment is being placed on bacterial 
resistance occurring in animal populations due to the past and the current wide 
use of antibiotics both in human and veterinary medicine, in food industry activities 
such as agriculture and animal production  and also in certain industries of the 
biotechnology area (3; 13-17; 26; 34; 59).  
 Several studies have accomplished to isolate antibiotic resistant bacteria 
from specimens of the various animal groups such as mammals, birds, 
amphibians, fish, and insects (3; 19; 26). The presence of antibiotic-resistant 
strains of bacteria in animals is, in a great percentage, the result of scavenging 
activities or contact with human-associated materials (19; 26).  
 The proliferating antibiotic-resistant microorganisms have a high potential 
for developing infections in many aquatic species and some, as supported by 
strong epidemiological and molecular evidences, being capable of transferring 
their resistance genes to human pathogens through Horizontal Gene Transfer 
(HGT) via mobile genetic elements such as plasmids and transposons, thus 
endangering human health (3; 7; 15; 16; 17; 19; 26). Beiwen Zheng et al. (2011) 
address this particular case of gene transfer from marine animal populations to 
terrestrial communities (7). During their research, they have found that a particular 
carbohydrate active enzyme codifying gene was transferred from marine bacteria 
to human gut microbiota, through ingestion of sea organisms, thus providing the 
opportunity for the transfer of any particular resistance genes from marine to 
terrestrial populations due to the extensive amount of gene transfer that occurs in 
the midst of the human gut microbiota (7; 14; 27). While inside the original host, 
these resistance genes are normally involved in metabolic networks but once they 
disseminate, they acquire one single role that is to confer resistance (7).  
 The transfer of resistance genes, in most cases, is done through HGT via 
several mechanisms (61). Such mechanisms are, for example, the transduction, 
where the genetic material is exchanged between different bacteria, usually 
carried by a bacteriophage, the bacterial conjugation process, where genetic 
components are transferred directly from the donor to the recipient cell through 
direct contact between them using mobile genetic elements capable of moving 
from one genetic location to another, like transposons, or from cell to cell without 
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requiring the process of conjugation, like plasmids (45, 61). These are capable of 
transfer resistance genes by processes of recombination which can or cannot 
include some form of replication (45). These gene carrying platforms and the very 
high rate by which bacteria are capable of suffering mutations in their DNA have 
permitted bacterial strains to occupy new areas of operation and niches, namely 
hospitals or animal producing farms were antibiotics are routinely used in 
enormous amounts, by being capable of expressing some particular genes that 
confer some phenotypic capability of resistance to the microorganism in these 
environments presenting specific ecological conditions (45). 
 
 
 
1.1. Antibiotics: chemistry, modes of action and mechanisms of resistance. 
 
 Antibiotics are chemical molecules produced either by microorganisms 
(bacteria and fungi) or be synthetically designed molecules (12).  
 The era of antibiotics started when they were first introduced in the 1930’s, 
after the remarkable discovery of penicillin in September of 1928 by Alexander 
Fleming when he noticed the lysis of Staphylococci colonies by a substance 
produced by a Penicillium spp. mold (12; 51). 
 Later in 1940, researchers Chain and Florey, together with their associates, 
were the first group to be able to produce a considerable quantity of penicillin 
obtained from cultures of Penicillium notatum (51).   
 Ten years later, the clinical use of penicillin G was profusely extensive but 
its application in the clinical settings proved to have serious limitations, such as its 
relative instability in gastric acid, a high susceptibility to β-lactamases enzymes 
(also known as penicillases) and the fact that this antibiotic is somewhat inactive 
against Gram-negative bacteria.  This inactivity is caused by the inability of the 
antibiotic to penetrate the Gram-negative cell wall, also to the lack of binding sites, 
the PBPs (Penicillin Binding Proteins) and finally, due to enzymatic inactivation. 
The need to improve the action of these molecules made the continuous research 
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on these antibiotics imperative which led, a few years later, to the isolation of the 
active moiety of the penicillin molecule, the 6-aminopenicillanic acid (51).  
 The 6-aminopenicillanic acid structure consists on a thiazolidine ring 
attached to a β-lactam ring which carries a secondary amino group (R-NH-), which 
makes a structure with a strong antibacterial activity.  This in turn led to the 
development and design of semisynthetic penicillins in order to overcome the 
shortcomings of penicillin G (51).   
 The establishment of the cephalosporin family, a molecule sharing the β-
lactam ring with penicillins resulted in an assortment of drugs with a varying 
capability to penetrate into different Gram-negative bacterial strains and to 
effectively oppose the action of numerous β-lactamases enzymes (51). 
 Since its discovery, antibiotics have been used to treat from mild to severe 
infectious diseases caused by bacteria and fungi, acting on them by blocking 
some essential process in microbial cells selectivity (12).  
 The production of antibiotics naturally results from the ability of a certain 
microorganism, in a pre-established habitat and a set of environmental conditions 
to affect the growth capabilities of other microorganisms in its surrounding area or 
to activate their elimination (12).  
 Today, the most well-known antibiotic producing group is the 
actinomycetes. In spite that antibiotics are able to have an antibacterial or 
antifungal activity there are no therapeutic agent highly effective both against 
bacteria and fungi at the same time. The reason for this is that both groups of 
microorganisms have different molecular and cellular targets. Another motive is 
the question of microbial cell penetration capability that varies amongst different 
classes of antibiotics (12).  
 The antibiotic mode of action is either bactericidal, where microorganisms 
are killed by the compound or bacteriostatic, in which, the microorganisms growth 
is rendered to a halt. In nowadays, most of the major classes of antibiotics in 
clinical use are naturally produced chemicals or semisynthetic derivatives. Yet, 
there are also synthetic antibiotics being used in the present day (12). 
 The three major classes of antibiotics used in this study were the β-lactams, 
the quinolones and the sulfonamides. 
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1.1.1. β-lactam antibiotics 
 
1.1.1.1. Chemistry of β-lactams 
 
 The β-lactamic group of antibiotics is composed of drugs characterized by 
having a β-lactam center ring in their stoichiometric chemical structure (22). 
 Some classes have a chemical structure composed of a thiazolidine ring 
attached to a β-lactam ring which carries a secondary amino group (R-NH-), (51). 
 
 
 
 
 
 
 
 
 
 The group is constituted by several classes, namely penicillins, 
cephalosporins, monobactams and also carbapenems, all having a bactericidal 
mode of action over microorganisms, exerting their action by inhibiting the 
synthesis of the bacterial cell walls. Bacterial cell walls are made of peptidoglycans 
which accounts for its rigidity (22).  Peptidoglycans are biopolymers with both a D- 
and a L-amino acids, being the only biological structure to have D-aminoacids). 
The basic structure consists on a carbohydrate backbone of alternating units of N-
acetyl glucosamine and N-acetyl muramic acid. The N-acetyl muramic acid 
residues make a cross-linkage with oligopeptides and the terminal peptide is 
usually D-alanine but other amino acids can became D-isomers and occupy the 
terminal position (70). 
 
 
 
 
Figure 1: Stoichiometric structure of the β-lactam 
molecule (62). 
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1.1.1.2. Mechanism of action of the β-lactam antibiotics 
 
 The β-lactam antibiotics work by inhibiting the Penicillin Binding Proteins 
(PBPs) trans- and carboxy-peptidases, the enzymes responsible for the cross-
linkage of the glycopeptides polymer units that compose the bacterial cell wall, 
weakening it and allowing the lysis process to occur (22). The lysogenic 
bactericidal action of these drugs are exerted only on the cell walls of growing 
bacteria, because they are undergoing cell wall synthesis but this exact 
mechanism is still unknown (51). 
  In spite of the fact that β-lactams all share the same bactericidal 
mechanism of action, the PBPs of different strains of bacteria have different 
affinities to different classes of β-lactams, thus exhibiting various degrees of 
susceptibility (22). The different susceptibility of both Gram-negative and Gram-
positive bacteria is due to differences in the PBPs receptor sites, to the relative 
amount of peptidoglycans present (the Gram-positive possess more than Gram-
negative), to the capability of the drugs to penetrate the external cell membrane of 
Gram-negative bacteria and to the capacity to resist to different types of β-
lactamase produced by different strains of bacteria (51).  
 The β-lactam antibiotics kill rate is lower when compared, for example, to 
aminoglycosides or fluoroquinolones. The bactericidal action starts after a lag 
period. It was found that β-lactams exhibit in vitro post-antibiotic effect against 
Gram-positive bacteria but not against Gram-negative bacteria, with the sole 
exception being carbapenems action on Pseudomonas spp. (51). 
 The efficiency of the β-lactams is dependent upon time and not of 
concentration, requiring that serum concentrations exceed the Minimal Inhibition 
Concentration (MIC – the lowest antibiotic concentration required to visibly inhibit 
the growth of a microorganism in a controlled test) of the pathogens for each 
dosage interval making the best administration of these drugs to be either with a 
frequent intake or by its continuous infusion into the organism (51).  
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1.1.1.3. Resistance to the β-lactam antibiotics 
 
 Resistance to the β-lactams is related intrinsically to the type and strain of 
bacteria. For example, in Gram-positive bacteria the phenomenon of resistance is 
achieved by the production of β-lactamases, enzymes that are capable of breaking 
the β-lactam ring of most penicillin compounds. These enzymes can, in some 
cases, be secreted extracellularly as inducible exoenzymes being mediated 
through plasmids (51). 
 The resistance shown by many Gram-negative bacteria to penicillin G 
results from the low permeability of their cell wall, the lack of PBPs and from the 
existence of a wide range of β-lactamase enzymes. Most Gram-negative bacteria 
express low levels of chromosomally mediated and species-specific β-lactamases 
within the periplasmic space which often contributes to the inherent resistance 
(51).  
 The β-lactamases work by hydrolyzing susceptible cephalosporins more 
rapidly than penicillin G but their hydrolysis capability is reduced on ampicillin, 
carbenicillin and β-lactamase-resistant penicillins (51). 
 The plasmid-mediated β-lactamases production is common amongst Gram-
negative and opportunist pathogenic bacteria. The majority of these enzymes are 
penicillases instead of cephalosporinases and after being constitutively expressed 
they are secreted into the periplasmic space causing a high level of resistance to 
β-lactams (51). 
 The most profusely spreaded enzymes are those classified by their 
hydrolytic activity such as TEM-type β-lactamases that promptly hydrolyse 
penicillin G and ampicillin instead of methicillin, cloxacillin or carbenicillin. The 
OXA-type β-lactamases are the least widespread and they hydrolyze penicillinase-
stable penicillins (oxacillin, cloxacillin and drugs related), (51). 
  It is considered that β-lactamases have probably evolved from PBPs as a 
sort of protective device in soil microorganisms highly exposed to β-lactams in 
their natural environments and spreaded by their production due to the activity of 
molds. Due to the large dissemination of transferable resistance, the production of 
β-lactamases by bacterial pathogens is now overreaching. Yet, a major milestone 
in the struggle against the effect of β-lactamases in β-lactam antibiotics was the 
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discovery of the broad-spectrum β-lactamases-inhibitory drugs such as clavulanic 
acid, sulbactam or still tazobactam. These particular drugs have a rather weak 
antibacterial activity but combined with penicillin G, ampicillin or amoxicillin they 
reveal an extraordinary synergism due to the characteristic irreversible binging of 
the β-lactamase enzymes of the resistant strains of bacteria. Still, other β-
lactamase enzymes inhibitors, such as cefotaxime and carbapenems do have a 
very strong bactericidal activity (51). 
 
 
 
1.1.2. Sulfonamides 
 
1.1.2.1. Chemistry of sulfonamides 
 
 The role of sulfonamides as antimicrobial agents diminished greatly over 
the past 70 years, since the introduction of β-lactams and other antibiotics due to 
generalized acquired resistance. Yet there is still an important part to be played by 
this group of drugs. When they are combined with trimethoprim (trimethoprim-
sulfamethoxazole or co-trimoxazole) or with ormetoprim the occurrence of 
resistance is vastly diminished, increasing its usefulness (51).  
 The sulfonamides derive from the sulfanilamide molecule, which contains 
the necessary structural design to have antibacterial activity. They only differ in 
having in the radical attached to the amino group (-SO2NHR), or occasionally in 
the substituent on the amino group (-NH2). The several derivatives vary in their 
physicochemical and pharmacokinetic properties as well as in the level of 
antimicrobial activity (51).  
 
 
 
 
Figure 2: Stoichiometric structure of the 
sulfamethoxazole molecule (63). 
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 Sulfonamides are rather insoluble being more soluble at an alkaline pH than 
in a solution with an acid pH value. Even in a mixture of sulfonamides, each 
component exhibits its own solubility. An excellent example of this is the 
trisulfapyrimidine preparation which results in the additive bacterial activity but in 
terms of solubility the agents behave independently. This mixture was specifically 
designed to offset the crystallization of sulfonamides in the acidic fluids inside the 
distal renal tubules and ureters (51).  
 Sulfonamides have sodium salts in their structure which are highly soluble 
in water and parenteral preparations are available for intravenous administration 
mode. These solutions produce a very alkaline reaction, with the exception of the 
sodium sulfacetamide, due to the fact that this compound is almost neutral, being 
available as an ophthalmic solution. In spite of this, there are sulfonamides 
molecules which are designed to have a low solubility in order to be gradually 
absorbed by the organisms. These molecules are used in the treatment of enteric 
infections (51). 
 
 
 
1.1.2.3. Mechanism of action of sulphonamides 
 
 The sulfonamides mechanism of action consists in interfering with the 
biosynthesis of folic acid by bacteria. It inhibits the biosynthesis of folic acid by 
preventing the para-aminobenzoic acid (PABA) from being inserted into the folic 
acid molecule (pteroyglutamic) through direct competition with the PABA 
molecules for the active center of the enzyme dihydropteroate synthetase (51). 
 Thus, the bacteriostatic action of sulfonamides depends heavily on the 
difference between bacterial and mammalian cells in correlation to their source of 
folic acid because all susceptible microorganisms must produce folic acid, contrary 
to mammalian cells which use preformed folic acid (51).  
 Therefore, sulfonamides bacteriostatic activity can be reversed by bacteria 
through an excess of PABA (51). 
 Sulfonamides are broad-spectrum antimicrobial agents, which are able to 
inhibit bacteria and protozoans like toxoplasma and coccidian, but its antibacterial 
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action nowadays is greatly diminished by the cumulative resistance that has been 
developing over the last 60 years since it has been used in the clinical setting (51). 
 The composition of the medium and the bacterial inoculum concentration 
greatly alters the MIC of sulfonamides (51).  
 Due to this fact, tests performed in vitro can, at times, present a false result 
for resistance in a certain bacterium. But, using a suitable control with a thymidine-
susceptible strain of Enterococcus faecalis this is generally avoided (51). 
 The best way to decrease the quantity of thymidine in the test medium 
when performing in vitro tests is to use Muller-Hinton agar medium containing 
lysed horse blood for it contains thymidine phosphorylase which will degrade the 
molecules present in the inoculum (51). 
 
 
 
1.1.2.4. Resistance to sulphonamides 
 
 The phenomenon of resistance develops slowly but steadily by 
chromosomal mutations which results from impairment of drug penetration into the 
bacterial cell, from the production of a insensitive dihydropteroate enzyme or from 
the overproduction of PABA (51). 
 Other mechanisms of resistance mediated by plasmids and integrons, often 
encoded by the sulI and sulII genes which are in turn occasionally linked to other 
resistance genes like the trimethoprim (dhfrI) or the streptomycin (aadA1a), are 
rather common, and in enteric bacteria is due to the impairment of drug 
penetration or the additional production of sulfonamide resistant dihydropteroate 
enzymes   (51). 
 The disseminated resistance to sulfonamides in bacteria isolated from 
animals attests for the intensive use that these drugs over the course of decades 
resulting in a complete cross-resistance among this group of drugs (51). 
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1.1.3. Fluoroquinolones 
 
 The group of fluoroquinolones, designated as well as quinolones, 4-
quinolones, quinolone carboxylic acids or by pyridine-β-carboxylic acids are a 
considerable sized and expanding group of synthetic antimicrobial molecules. 
 The primary compound of this group was nalidixic acid which was first 
depicted in 1962 and introduced for clinical practices in the year of 1963 but only 
being approved for medical therapeutic purposes in 1965 (51).  
 Because nalidixic acid revealed to have restricted clinical applications as a 
result of a low rate of absorption following oral administration, a moderate 
antibacterial activity, a high rate of protein binding capability (92%-97%) and a 
poor physiological tolerance, soon attempts were made to design an intravenous 
form of the nalidixic acid but without positive results (51).  
 Only from the middle 1960’s to the early 1980’s were various new 
quinolones approved to be used in a clinical setting (e.g. pipemidic acid, piromidic 
acid, oxolinic acid and flumaquine). In spite of the augmented antibacterial activity, 
these new drugs continued to have low absorption levels and physiological 
distribution capability (51).  
 Later, in the 1980’s with the addition of a fluorine molecule was made to the 
6-position of the basic chemical structure of the quinolone, together with the 
substitution of a piperazine on position 7, the antibacterial capabilities of these 
compounds were enhanced. This range of capabilities included the activity against 
microorganisms such as Pseudomonas aeruginosa and staphylococci, and at the 
same time it heightened the level of oral absorption and systemic distribution.  
 Norfloxacin was the first fluoroquinolone to be approved for clinical uses, 
seconded shortly after by ciprofloxacin (51). 
 The fluoroquinolones have a fast bactericidal activity in an appropriate drug 
concentration (Minimum Inhibitory Concentration - MIC ratios), showing a killing 
action dependent of concentration and possibly a prolonged post-antibiotic effect 
(PAE) in vivo in some bacteria. In spite of this, there is a huge potential for the 
rapid selection of resistance to these drugs by some pathogens which as turn out 
to be a shortcoming of this class of antibiotics (51). The way to circumvent this 
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issue is to select an appropriate dosage targeting a specific pathogen and the 
correct infectious disease process (51). 
 The classification of fluoroquinolones is based upon their chemical structure 
and biological activities (51).  
 Following an analysis of their chemical structure, the classification scheme 
depends on the number of rings associated with the pyridine-β-carboxylic acid 
nucleus.  Accordingly, Group I is composed by the monocyclic derivatives and 
Group II, which comprises the largest amount of fluoroquinolones commercialized 
today, consists on bicyclic derivatives (51). 
 However, Group II is divided into two smaller subgroups based on 
substitutions in the 8th position of the fluoroquinolone nucleus (51). 
 The Group III is comprised of tricyclic derivatives, including marbofloxacin 
(51). Group IV includes quadricyclic molecules, of which only very few have been 
synthesized until the present day (51). 
 When the classification is based on the biological aspects of 
fluoroquinolones, then the categorization system comprises three groups with 
Group I being composed by quinolones that exhibit specific activity against 
Enterobacteriaceae (nalidixic acid and flumaquine) and could even be divided into 
molecules that are metabolized and those that are not such as oxolinic acid and 
pipemidic acid (51). 
 The Group II of this system is composed of molecules that have an 
extended spectrum of antibacterial activity, which includes the almost all of the 
fluoroquinolones, with the exception of a single one. Likewise, this group can be 
subdivided in two subgroups, subgroup IIA and IIB, depending on whether the 
molecules are metabolized or not. Group III has only one fluoroquinolone, which is 
pradofloxacin (51).  
 Nevertheless, grouping of fluoroquinolones can also be done based upon 
the physicochemical properties of these molecules. Research on new compounds 
now emphasizes the replacement of the fluorine atom in position 6 which may 
decrease the side effects, the metabolism and possible interactions with other 
drugs (51). 
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1.1.3.1. Chemistry of fluoroquinolones 
 
 Fluoroquinolones is a group composed of synthetic compounds (51).  
 The first 4-quinolone type compound (nalidixic acid) to be approved for 
clinical use lacked various characteristics associated with the fluoroquinolones, for 
example, having a nitrogen atom in the position 8 instead of a carbon atom (51).  
 Possessing a nitrogen atom located in position 1, the nalidixic acid exhibits 
two nitrogen atoms in its nucleus, turning it into a naphthyridone molecule instead 
of a quinolone molecule (51).  
 
 
 
 
Figure 3: Stoichiometric structure of the 
fluoroquinolone molecule (64). 
 
 
 
 
 
 
 Contrary to other quinolones, nalidixic acid is not halogenated (51).  
 Following the discovery of nalidixic acid and its antibacterial activity, more 
than 10000 compounds have been developed from the bicyclic 4-quinolone matrix 
molecule. However, the nalidixic acid has a few clinical limitations, including a 
constricted spectrum of antibacterial activity, weak pharmacokinetic properties, 
toxic side effects and the capacity to induce a quick resistance capability in 
microorganisms. But changing the hydrogen atom in position 6 of the 4-quinolone 
molecule by a fluorine atom resulted in a rise of its activity against Gram-negative 
and Gram-positive bacteria alike (51). 
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1.1.3.2. Mechanism of action of fluoroquinolones 
 
 Quinolones produce their anti-bacterial action through the inhibition of 
bacterial DNA synthesis (9; 23) It promotes the cleavage of the DNA sequences in 
the DNA-enzyme complexes of type IV topoisomerase and DNA gyrase (9; 23). 
 These enzymes are composed of two pairs of subunits. The type IV 
topoisomerase enzyme is composed by parC (75 kDa) and parE (70 kDa) and it 
acts in the bacterial DNA structure by processing the removal of positive or 
negative supercoils and it can catenate and decatenate circular DNA molecules 
(23). The DNA gyrase also has the capability of both introducing and removing 
positive or negative supercoils in the DNA structure and is able also to catenate 
and decatenate closed circular DNA molecules (9; 23). These two enzymes 
produce, during their action, a breakage in both strands of DNA, followed by an 
ATP-dependent reaction were they insert a second DNA double helix through that 
breakage point, resealing it. This reaction is blocked by quinolones by trapping the 
enzymes in a drug-enzyme-DNA complex. This event produces a release of 
double-stranded DNA breaks which are lethal to the microorganisms (23). 
 The majority of bacteria have these pair of enzymes but only a few can 
survive having only a functional DNA gyrase. The DNA gyrase from Gram-
negative bacteria is more susceptible to be inhibited by quinolones than is the type 
IV topoisomerase. In Gram-positive bacteria type IV topoisomerase is the prime 
target, leaving DNA gyrase less susceptible (23).  
 Similar to the other antibiotics, Quinolones possess a bactericidal capability 
dependent on its concentration. It becomes more evident as the antibiotic serum 
concentration reaches a level of 30 times the amount of MIC. However, for higher 
serum concentrations of antibiotic, RNA and protein synthesis are inhibited, 
decreasing its antimicrobial activity (9; 23).  
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1.1.3.3. Resistance to fluoroquinolones 
 
 The resistance manifested by bacteria to the action of fluoroquinolones 
results from target modification due to chromosomal mutations, by a decrease in 
the permeability of the bacterial cell membrane, through the mechanism of efflux 
pumps or by target protection (51). 
 The mutations that can induce a phenomenon of resistance will occur first 
in gyrA in Gram-negative bacteria and in parC in Gram-positive bacteria (23). 
Resistance is accomplished by amino acid replacements in the gyrA or parC 
subunits region known as “quinolone-resistance determining region” (QRDR), a 
region that occurs in the DNA-binding surface of the enzymes (23).  
 Following a first-step mutation in the DNA gyrase of a Gram-negative 
microorganism, supplementary mutations in gyrA, gyrB or on parC may produce 
an augment in bacterial resistance, but isolated they are ineffective in bacteria 
carrying wild type gyrA, due to the fact that the most susceptible target determines 
the level of susceptibility (23). 
 Nevertheless, the main mechanism by which bacteria are considered to be 
able to protect themselves from the bactericidal action of fluoroquinolones and 
antibiotic drugs in general is by creating obstructions to antibiotic entry inside the 
cell. This can be achieved by simply modifying the cell membrane composition or 
by increasing the efflux of the antibiotic to the extracellular environment (27; 42). 
Efflux pumps offer several mechanisms of resistance because they are able to 
pump a variety of toxins, like heavy metals and many other toxic molecules, to the 
external environment. Some pumps, through chromosomal modifications, are 
considered to play a primary role in environmental terms, for example, by 
providing tolerance to toxic compounds (27).  
 The microbiota of insect guts without any previous exposure to antibiotics 
exhibited efflux pumps with the inheriting capacity to provide resistance to 
antibiotics when transferred to E. coli (27; 42). 
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2. Objectives 
 
 The objectives of this study, in accordance to the contextual analysis made 
in the introductory chapter, were: 
 
1 – first, to determine the existence of antibiotic-resistant strains of bacteria both in 
animals from aquacultures and in animals from commercial fishing; 
  
2 – and second, to determine the probable differences exiting at the microbiologic 
level between the different sampling sites, commercial fishing versus aquaculture 
and between the commercial harbors, north and south of the Douro river. 
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3. Materials and Methods 
 
 The reference data concerning the natural GIT microbiota of the Sole fish 
was determined by comparing wild animals with those produced in captivity using 
two different locations; the first being collected north of the Douro river, in Póvoa 
do Varzim, in an aquaculture operating a flow-through system. The second 
aquaculture is located south of river Douro, in the area of Aveiro and it uses a 
recirculating system which is completely closed to exterior environment when in 
full production mode. The animals obtained in aquaculture producing facilities 
were all from the same species, Senegalese sole, fed artificially and reared in two 
different systems of production. 
  The fish originated from commercial fishing where collected also north of 
the Douro river in the commercial harbor of Leixões and south of the Douro river 
respectively, in the commercial harbor of Aveiro.  
 The first lot of fish was acquired in the Leixões harbor followed by the 
aquaculture in Matosinhos area both in January 2011. The second lot was 
acquired in the aquaculture in the region of Aveiro and in the Aveiro harbor both 
on the end of March 2011. The animals were all adults (sizes of the animals) and 
the sampling size consisted of five live animals (n=5) per location amounting to a 
total experimental sample size of 20 (ntotal=20), with a naquaculture=10 and nocean 
fishing=10 respectively.  
 Once the animals were acquired, they were immediately transported alive, 
inside small tanks containing water taken from their rearing facilities, to the 
laboratory in the Department of Biology at the University of Aveiro, where they 
were painlessly sacrificed by hypothermia and the fresh guts were removed 
aseptically in the laboratory. 
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3.1. Aquaculture systems 
 
 There were significant technical differences between the two aquaculture 
systems of production. 
 The first aquaculture industry is located north of river Douro and it operates 
a flow-through system where the sea water is pumped directly to the rearing tanks 
after being filtered in special filtering systems. Being a continuous flowing 
circulation system, the water from the rearing tanks flows out to the ocean having 
discarding the amounts of organic matter and wastes in solution resulting from the 
artificial feeding at the downstream end of the system (21).  
 The second aquaculture, located south of the Douro river in the area of 
Aveiro, uses a recirculating system in which the water flowing system is 
completely closed to exterior environment when in full production mode (21). 
 The fish are raised in long tanks called nurseries and then, at a stage near 
adulthood, they are transferred to wider and deeper tanks. In all these they carry 
out all their biological activities (21).  
 The optimal biophysical conditions of the water are maintained by a special 
filtering system were a primary filter at the exit of the tanks removes the particulate 
wastes (21). Then the water is conducted to a biological filter were wastes 
resulting from excretion are detoxified by bacteria (21). Toxic ammonia and nitrites 
(NO2-) are converted into nitrate (NO3-), a non-toxic form to the animals, and the 
water is inserted back into the rearing tanks (21). The amounts of water lost are 
very low (< 5%) of the each daily volume of water, so little new water is needed to 
be added (21). An air induction system maintains the oxygenation of the fish tanks 
and the filtering system in optimal levels (21). 
 
 
 
 
 
 
 
 
27 
 
3.3. Bacterial isolation methods 
 
 The animals were sacrificed by hypothermia. The process consisted on 
immersing the animals in ice for 30 min. after which they were dissected and for 
each gastrointestinal tract (GIT) the following protocol was applied:  
 
 insertion into Falcon 50 mL tubes with Tryptone soya broth growth medium 
(TSB) from Sigma-Aldrich Chemie GmbH;  
 
 incubation at 37ºC for 24h to guaranty the growth of the bacterial strains 
present in the biological samples; 
 
 the samples were always stored at the end of each day at the temperature 
of 4ºC. 
 
 
 
  The next phase of the protocol, after the 24h period of incubation, 
commenced by: 
 
 process of bacterial isolation - inoculation of 150 µL of sample in 3 Petri 
dishes containing MacConkey growth medium agar using previously 
standardized made plates from Biomérieux MacConkey agar 20 plaques kit. 
The sample was applied on the dish by scattered seeding in order to isolate 
the bacterial strains by depletion. 
 
 
 This step was done in order to make a first bacterial strain isolation 
procedure after the starting inoculation of the gastrointestinal biological extracts. 
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 The conditions were replicated in order to refine the isolation procedure of 
the bacterial strains existing in the sample by using: 
 
 Biomérieux MacConkey agar 20 Petri dishes kit growing at 37ºC over a 24h 
period.  
 
 
 
 Because there were signs of swarming (bacterial mobility) in some bacterial 
colonies, again we performed the culture of these motile colonies using: 
 
 Biomérieux CLED (Cysteine Lactose-Electrolyte-Deficient) growth medium 
agar standardized plates (highly effective in preventing swarming 
phenomenons in the inoculated growth plates), (68). 
 
 
 
3.3.1. Bacterial susceptibility testing 
 
 The next step on our work protocol consisted in performing the Kirby-Bauer 
growth inhibition testing using: 
 
 trimethoprim-sulfamethoxazole (SXT) impregnated standardized testing 
discs; 
 
 penicillin impregnated standardized testing discs; 
 
 amoxicillin combined with clavulanic acid impregnated standardized testing 
discs (compound known as amoxiclav); 
 
 ciprofloxacin impregnated standardized discs; 
 
29 
 
 the antibiotic discs were placed over the GIT bacterial isolates inoculates on 
Biomérieux Muller-Hinton (MHT) agar medium base plates. 
 
 
 
 The results were registered and treated statistically using Microsoft Excel 
2007 producing the statistical correlation between the data acquired. 
 The graphics were made using an n value equal to the number of results 
per phenotype in the Kirby-Bauer inhibition testing (n=number of phenotypes per 
site) divided by the total number of results for each sampling site (n(total number of Kirby-
Bauer per sampling site): 
 
Percentage of resistant strains per antibiotic = n(per phenotype) / n(total number of Kirby-Bauer 
results per sampling site).  
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4. Results 
 
 The results from the Kirby-Bauer inhibition testing produced the following 
graphics: 
 
 
Graphic 1: Percentage of resistant strains – aquaculture of Aveiro. 
 
  
Graphic 2: Percentage of resistant strains – commercial harbor of Aveiro. 
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Graphic 3: Percentage of resistant strains – aquaculture of Póvoa do Varzim. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graphic 4: Percentage of resistant strains – commercial harbor of Leixões. 
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Graphic 5: Total percentage of resistant strains in the two aquacultures. 
 
 
Graphic 6: Total percentage of resistant strains in the two commercial harbors. 
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5. Discussion  
 
 The careful analysis of the results quickly permits a rapid evaluation of the 
considerable differences in the percentages of resistant strains of bacteria 
between the animals collected by commercial fishing on the north and south of the 
Douro river.  
 Analyzing Graphic 2 it is visible the percentages of 100% of resistance 
phenotypes to both penicillin and ciprofloxacin with 100% of sensitive phenotypes 
to sxt and amoxiclav.  
 In graphic 4 the results are somewhat better, with only 100% of resistant 
phenotypes to penicillin and 100% sensitive phenotypes to all other three 
antibiotics, sxt, amoxiclav and ciprofloxacin. 
 The statistical analysis made to the aquaculture systems reveals several 
interesting results.  The graphic 1 represents the aquaculture in Aveiro which uses 
a full recirculating system, which showed a full 100% of resistance phenotype by 
bacterial strains to penicillin and amoxiclav, 2% and 8 % of intermediate 
phenotype both to sxt and ciprofloxacin, together with 72% and 82% of sensitive 
phenotypes to sxt and ciprofloxacin respectively. 
 On the other hand, graphic 3, representing the aquaculture in Póvoa do 
Varzim which uses a flow-through system, revealed a similar but yet a bit slightly 
different pattern, by showing 100% of resistant phenotypes to penicillin and 40% of 
resistant phenotypes to sxt and amoxiclav. In terms of sensitive phenotypes it 
revealed 60% to sxt and ciprofloxacin and 20% to amoxiclav. 
 The differences between the percentages of resistant strains in commercial 
fishing and aquaculture production on fish are shown in graphics 5 and 6. 
 The results in graphic 5 represent the aquaculture production and they 
show the existence of a full 100%, 82% and 11% of resistant phenotypes to 
penicillin, amoxiclav and sxt respectively, 18% of intermediate phenotypes to sxt, 
ciprofloxacin and 12% of intermediate phenotypes to amoxiclav. 
 It also revealed the presence of 71%, 6% and 82% of sensitive phenotypes 
to sxt, amoxiclav and ciprofloxacin respectively. 
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 The results in graphic 6 represent the total set of results for commercial 
fishing and they reveal a total of 100% and 75% of resistant phenotypes to 
penicillin and amoxiclav respectively and 100% of sensitive phenotypes both to sxt 
and ciprofloxacin and 25% of sensitive phenotypes to ciprofloxacin. 
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6. Conclusions 
 
 The differences registered in commercial fishing between north and south 
of the Douro river reveal that, in the case of the fewer percentages of resistant 
strains of bacteria obtained in the north, is most likely due to the dilution effect 
provided by the oceanic currents that run mainly from north to south along the 
entire Portuguese coast. This constant flux of oceanic water tends to dilute any 
concentration of pollutants (chemical or organic) that may come to be drained in 
effluents out to sea, therefore reducing the possibility of contact of the wild animals 
with any antibiotic compound.  
 The larger percentages of resistant phenotypes registered south of the 
Douro river are most likely to have their origin on the contamination by the 
industrial and hospital effluents from the Aveiro urban area. Here we should 
realize that Aveiro is a heavy industrialized region but we also must not forget the 
possible influence of the Douro river which may carry in its flow large amounts of 
contaminants from all the industrial and urban areas along its final stretch to the 
ocean (Porto urban area). 
 The industrial and hospital effluents are usually the largest sources of 
contaminants, carrying antibiotic molecules and chemicals in suspension which 
later precipitate onto the ocean bed out at sea due to physico-chemical conditions 
such as their molecular weights, pH values in the ocean waters, temperature and 
salinity values and even pressure. 
 The differences registered between the two aquaculture system are 
undoubtedly related to their systems of water circulation and production. In the 
case of the aquaculture using the flow-through system, its higher percentages of 
resistant and intermediate phenotypes are most likely to have been originated by 
external pollutant sources, since it uses a continuous water circulating system, 
pumping water from the sea directly into the rearing grounds. This increases the 
probabilities that the fish will come into contact with some external antibiotic and 
chemical contaminants inside the production facilities. The physical and biological 
environmental influences cannot be discarded. The possible influence of human 
activities, especially the overuse of antibiotics in health units and even inside the 
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family nucleuses that go out to sea in the drainage of human wastes and runoffs, 
spreaded by the ocean currents thus increasing the contact of even the GIT 
microbiota of these animals, sheltered inside closed rearing tanks with repeated 
doses of antibiotics and possibly with external resistant microorganisms that can 
transmit the resistance genes to the GIT microbiota of the Sole fish. 
 One other possibility is the use of antibiotics in the animals food supply 
since the industry of animal production is known to make the prophylactic use of 
antibiotics, even in minimal amounts according to the legal standards, but which 
could impose an artificial selective pressure to the GIT microbiota of the fish inside 
the tanks which, by living in close quarters, will increase even more the exchanges 
of genetic determinants amongst the population of the aquaculture, leading to 
increased percentages of resistance in the bacterial phenotypes. 
 The aquaculture in Aveiro uses a recirculating system, were the water 
flowing system is completely closed to the outside environment. This excludes de 
possibility of external influences, therefore, leaves us only with the probability of 
either two things, the possible use of antibiotics in the fish food supply which will 
directly influence the GIT microbiota of the animals, leading eventually to the 
appearance of resistant phenotypes with the prolonged exposure to these 
molecules. The second alternative is that there is a possibility of contamination of 
the water flowing system either by the use of some kind of biological filter unknown 
to this study or through the accumulation of microbial strains along the systems 
which in the right kind of environmental settings could have developed some 
degree of resistant phenotype later transmitting the genetic determinants to the 
fish GIT microbiota coming into contact with them by the recirculating water inside 
the system. 
 The differences between commercial fishing and aquaculture production 
regimes are well compared by graphics 5 and 6. The lesser percentages found in 
commercial fishing are probably the result of the pollutant dilution effect brought 
about by the ocean currents and physico-chemical conditions. The velocity, 
temperature, salinity, pH and even density of the oceanic waters vary constantly 
and that can exert a considerable clearing effect over any molecular concentration 
that may have been cast into the sea waters.  
45 
 
 The larger percentages of resistant phenotypes found in aquacultures are 
probably the result of either the incorrect use of antibiotics in the animals fodder or 
perhaps even from the natural induction of resistant phenotypes occurring in the 
microbiota of the Solea spp. which, in association with HGT vectors (conjugation, 
transposition and transduction), creates an extremely high potential for the 
exchange of genes conferring resistance to neighboring phenotypically sensitive 
strains of bacteria. 
 Ultimately, these genetic and ecological processes create the possibility 
that the genes which code for the resistant phenotypes in the fish GIT microbiota 
may come to be inserted in the human gastrointestinal microbiota by the 
consumption of marine organisms, which may induce changes in the normal 
human GIT microbiota creating the conditions for the selection of antibiotic-
resistant strains. 
 This study, therefore, recommends that a greater control must be made 
over the general use of antibiotics and that a greater number of microbiologic and 
genetic studies be made in order to monitor the possible development of the 
percentage of antibiotic-resistant strains of bacteria.  
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